Headache Clinical Trial
Official title:
Yoga for Pediatric Tension-Type Headache
This study will determine the efficacy of an 8-week Hatha yoga intervention for adolescents with tension-type headache (TTH) and will assess theoretically-driven mediators of treatment response, including experimental pain sensitivity, chronic stress, and negative cognitions linked to chronic pain.
Adolescents (ages 13 to 18) with TTH will be randomly assigned to either a Hatha yoga
intervention (n = 20) or a wait-list control condition (n = 20). The yoga intervention will
consist of 8 weekly classes lasting one hour each taught by an experienced yoga teacher.
Each class will have a maximum of 10 participants. A baseline assessment including an
experimental pain protocol, questionnaires, and hair samples (to determine cortisol
concentrations in the past month) will be completed prior to the intervention. Biweekly
questionnaires will be completed by both intervention and wait-list groups during the 8-week
intervention period. The post-intervention assessment will include the experimental pain
protocol, questionnaires, and hair samples (to determine cortisol concentrations in the past
month). The wait-list control group will subsequently receive the yoga intervention and
complete post-intervention and follow-up assessments (i.e., the wait-list group will
complete one more experimental pain protocol and will provide one more hair sample than the
intervention group); these data will then be merged with that of the yoga group to examine
pre- and post-intervention effects. Both intervention and wait-list groups will complete
questionnaires 3 months following completion of the yoga protocol.
Specific Aim 1: To determine the safety, feasibility, and acceptability of an 8-week Hatha
Yoga Protocol (HYP) in adolescents (ages 13 to 18) with tension-type headache (CTTH).
Hypothesis: At least 80% of adolescents will complete the HYP. Attrition rates will be
compared between HYP and control groups to determine whether results may be biased given
different durations of the study protocols between the two groups and interval between
recruitment and intervention (i.e., control group will be in the protocol for two additional
months and the intervention will be delayed by 8 weeks).
Specific Aim 2: To evaluate changes in primary outcomes (frequency and intensity of
headaches, pain-related functional disability, health-related quality of life, medication
use) from baseline to post-intervention in the HYP and usual care wait-list controls.
Hypothesis: Participants in the HYP group will demonstrate greater reduction in headache
frequency and intensity, decreases in pain-related functional disability, improvement in
health-related quality of life, and reduction in medication use compared to wait-list
controls from baseline to post-intervention. Secondary analyses will examine changes from
pre- to post-intervention for the entire sample once the waitlist group has completed the
HYP; in addition, sustained intervention effects will be determined by examining changes
from post-intervention to 3-month follow-up for the entire sample.
Specific Aim 3: To assess changes in potential mediators of clinical outcomes following the
HYP, including responses to experimental pain [conditioned pain modulation (CPM), temporal
summation to second pain (TSSP)], alterations in stress response systems [hair cortisol
concentrations, self-reported stress levels, stress hormone responses to experimental pain
(cortisol, alpha-amylase, DHEA), heart rate variability responses to experimental pain] and
pain-related cognitions (catastrophizing, self-efficacy, acceptance). Hypothesis:
Participants in the HYP group will show increased CPM, decreased TSSP, reduced hair cortisol
concentrations and self-reported stress levels, lower cortisol and alpha-amylase responses
to experimental pain, higher DHEA responses to experimental pain, lower heart rate
variability prior to experimental pain, reduced pain catastrophizing, increased pain
self-efficacy, and increased pain acceptance compared to wait-list controls at
post-intervention.
Although yoga has shown promise as a complementary health approach for chronic pain in
adults, few studies have examined the potential efficacy of yoga for adolescents with
chronic pain. Anticipated findings from the proposed study will help to determine whether -
and how - an 8-week yoga intervention can improve pain-related outcomes in adolescents with
TTH; these findings will be critical for refinement of the HYP for youth with TTH and for
the design and implementation of a larger-scale, randomized controlled trial with an active
control condition.
Background and Significance
TTH is common in youth and associated with significant functional disability. Complementary
health approaches such as Hatha yoga, which emphasize physical postures, breathing
exercises, and meditation, have been shown to reduce chronic pain-related disability. The
only known pilot study of yoga for youth with headache showed moderate but non-significant
improvement in daily functioning from baseline to post-intervention (Hainsworth et al.,
2014). A randomized controlled trial of yoga for headache pain in adults found that the yoga
group exhibited reduced migraine frequency and intensity, lower pain severity, and less
medication use for headache compared to the control group after 12 weeks. Potential
mechanisms underlying improvements in pain outcomes following yoga interventions include
physiological, behavioral and psychological changes. Adults with TTH are characterized by
impaired CPM and enhanced TSSP. Moreover, increased pain sensitivity in adults with TTH
appears to be exacerbated by chronic stress, sustained physiological arousal, and negative
cognitions. The proposed study addresses a critical gap in the literature by investigating
the safety, feasibility, and efficacy of Hatha yoga as a complementary treatment approach
for youth with TTH.
Preliminary Studies
Members of this research team have previously employed a similar experimental pain protocol
to demonstrate elevated TSSP in female adolescents with functional abdominal pain, elevated
TSSP in adolescents with both functional abdominal pain and a history of physical or sexual
assault/abuse, and racial differences in both TSSP and CPM in healthy youth ages 10 to 17.
Sample Size Justification and Statistical Analysis Plan
Sample size estimation: Prior yoga interventions in youth with chronic pain suggest
medium-to-large effect sizes (Cohen's d comparing mean changes from baseline to
post-intervention) for indices of changes in pain-related functional disability. For power
calculations, G*Power 3.1.9.2 was used to estimate the sample size required for estimated
effect sizes ranging from .50 to .80. Assuming a Type I error rate of α = .05 and
statistical power of 0.80, results indicated a range from 16 to 34 total participants.
Assuming a 20% attrition rate and adopting the more conservative anticipated total n = 34,
the investigators estimate that 40 total subjects will need to be recruited (20 per group).
Data analytic strategy: Group differences in primary outcomes (Specific Aim 2) will be
tested using analysis of covariance, controlling for baseline scores on these outcome
variables. An intent-to-treat analysis of primary outcome measures (including all enrolled
participants and utilizing the last observation carry forward approach) will be conducted to
confirm findings in participants who complete the HYP.
A series of linear regressions will test the direct effects of the intervention on outcome
variables and the indirect effects of mediators on the relationship between mediator and
outcome (Specific Aim 3). Mediation analyses will be run using the Preacher and Hayes (2008)
SPSS Macro for Multiple Mediation. In order for statistical mediation to occur, two criteria
are necessary: 1) there is an effect to be mediated (i.e., a significant association between
intervention and the outcome), and 2) the indirect effect of intervention on outcome via
mediator was significant. The indirect effect will be considered significant at the p < .05
level if the corresponding bootstrapped confidence interval does not contain zero.
Bootstrapping procedures will test each mediation model by generating a 95% confidence
interval (bias corrected) around the indirect effect test statistic in a series of 1000
Bootstrap samples repeatedly drawn from the full sample.
Potential limitations. The pilot study sample size is modest but will yield critical data
regarding effect sizes for primary pain-related outcome variables as well as potential
mediators of treatment effects.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Withdrawn |
NCT03472872 -
A Comparative Efficacy Trial of IV Acetaminophen Versus IV Ketorolac for Emergency Department Treatment of Generalized Headache
|
Phase 4 | |
Withdrawn |
NCT05410366 -
Safe Harbors in Emergency Medicine, Specific Aim 3
|
||
Withdrawn |
NCT02866084 -
Neuromodulation Treatment of Vestibular Migraines
|
N/A | |
Active, not recruiting |
NCT03537573 -
Provider-Targeted Behavioral Interventions to Prevent Unsafe Opioid Prescribing for Acute Pain in Primary Care
|
N/A | |
Recruiting |
NCT05891808 -
miR-155 Expression in Episodic and Chronic Migraine
|
||
Not yet recruiting |
NCT04352218 -
Safety Profile of PETALO CVS in the Treatment of Non-thrombotic Internal Jugular Vein Stenosis and Chronic Headache
|
Phase 2 | |
Completed |
NCT02734992 -
Acceptance and Commitment Therapy vs Medical Treatment as Usual Wait-list Control for Primary Headache Sufferers
|
N/A | |
Completed |
NCT01327118 -
Prostaglandin F2alpha in a Human Headache Model
|
N/A | |
Completed |
NCT01153789 -
Study of Oculomotor Dysfunction Leading to Children Vertigo
|
N/A | |
Not yet recruiting |
NCT00969995 -
Identification of Inflammatory Markers in Migraine Patients
|
N/A | |
Not yet recruiting |
NCT00752921 -
Randomized Placebo Controlled Trial With Etoricoxib That is Taken to Prevent the Yom Kippur Headache
|
Phase 4 | |
Completed |
NCT00212810 -
Evaluation of the Effectiveness of Topiramate in Preventing the Transformation From Episodic Migraine to Chronic Daily Headache.
|
Phase 4 | |
Terminated |
NCT00291395 -
PGI2 Induced Headache and Cerebral Haemodynamics in Healthy Volunteers
|
Phase 1 | |
Completed |
NCT00263094 -
An End to the Yom Kippur (and Ramadan) Headache
|
N/A | |
Completed |
NCT00135122 -
Prednisolone in the Treatment of Withdrawal Headache in Probable Medication Overuse Headache
|
Phase 3 | |
Completed |
NCT02475005 -
An Intervention to Improve Adolescent Headache Self-management
|
N/A | |
Completed |
NCT03163901 -
The Effect of OMT on Functional Outcomes and Anti-inflammatory Biomarkers in Mild to Moderate Traumatic Brain Injury
|
N/A | |
Completed |
NCT01664585 -
Exercise Training With Physically Active Lifestyle to Reduce Headache and Quality of Life
|
N/A | |
Completed |
NCT04632420 -
Evaluation of Headache and Childbirth in a Chronic Pain Population
|
||
Recruiting |
NCT05033613 -
Home Blood Pressure Monitoring Before and After COVID-19 Vaccination in Patients at High Risk of Cardiovascular Disease
|